These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26907852)

  • 1. TWEAK/Fn14 signaling: a promising target in intervertebral disc degeneration.
    Liu YP; Yuan CM; Zhang SG; Hao QH; Wang MM; Zhang Z; Meng Q; Li M; Hao YD
    Histol Histopathol; 2016 Sep; 31(9):943-8. PubMed ID: 26907852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
    Xu WD; Zhao Y; Liu Y
    Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Tweak/Fn14 signaling pathway as a potent target for controlling bone loss.
    Du YY; Zhao YX; Liu YP; Liu W; Wang MM; Yuan CM
    Biomed Pharmacother; 2015 Mar; 70():170-3. PubMed ID: 25776497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
    Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
    Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.
    Burkly LC; Michaelson JS; Zheng TS
    Immunol Rev; 2011 Nov; 244(1):99-114. PubMed ID: 22017434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
    Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
    Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK and Fn14: new molecular targets for cancer therapy?
    Winkles JA; Tran NL; Berens ME
    Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade.
    van Kuijk AW; Wijbrandts CA; Vinkenoog M; Zheng TS; Reedquist KA; Tak PP
    Ann Rheum Dis; 2010 Jan; 69(1):301-4. PubMed ID: 19147618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of TWEAK, Fn14, and TGF-beta1 on Degeneration of Human Intervertebral Disc.
    Huh H; Lee YJ; Kim JH; Kong MH; Song KY; Choi G
    J Korean Neurosurg Soc; 2010 Jan; 47(1):30-5. PubMed ID: 20157375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-like weak inducer of apoptosis association with proliferative diabetic retinopathy and promotes proliferation and collagen synthesis in retinal ARPE-19 cells.
    Chen DY; Su GF
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
    Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
    Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia.
    Vendrell J; Maymó-Masip E; Tinahones F; García-España A; Megia A; Caubet E; García-Fuentes E; Chacón MR
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2983-92. PubMed ID: 20382683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
    Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
    J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis.
    Chen J; Wei L; Xia Y
    Nephrology (Carlton); 2017 Feb; 22(2):101-106. PubMed ID: 27786399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
    Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
    J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK/Fn14 signaling in tumors.
    Hu G; Zeng W; Xia Y
    Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.